The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103799 · Cited by 2,172
Self-citationPujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., Sorio, R., Vergote, I., Witteveen, P., Bamias, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4489 · Cited by 1,622
van Dam, G. M., Themelis, G., Crane, L. M. A., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J. G., van der Zee, A. G. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2472 · Cited by 1,545
Aghajanian, C., Blank, S. V., Goff, B. A., Judson, P. L., Teneriello, M. G., Husain, A., Sovak, M. A., Yi, J., & Nycum, L. R. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.0505 · Cited by 1,384
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Juno is the egg Izumo receptor and is essential for mammalian fertilization
Bianchi, E., Doe, B., Goulding, D., & Wright, G. J. (2014) · Nature · doi:10.1038/nature13203 · Cited by 671
Leamon, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.008 · Cited by 558
Li, T., Kung, H.-J., Mack, P. C., & Gandara, D. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3753 · Cited by 518
Kelemen, L. E. (2006) · International Journal of Cancer · doi:10.1002/ijc.21712 · Cited by 509
Cellular Heterogeneity and Molecular Evolution in Cancer
Almendro, V., Marusyk, A., & Polyak, K. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163923 · Cited by 498
Antony, A. C. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.002441 · Cited by 470
Utilizing the folate receptor for active targeting of cancer nanotherapeutics
Zwicke, G. L., Ali Mansoori, G., & Jeffery, C. J. (2012) · Nano Reviews · doi:10.3402/nano.v3i0.18496 · Cited by 458
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Gonen, N., & Assaraf, Y. G. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.07.002 · Cited by 437
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
Schwarz, R. F., Ng, C. K. Y., Cooke, S. L., Newman, S., Temple, J., Piskorz, A. M., Gale, D., Sayal, K., Murtaza, M., Baldwin, P. J., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001789 · Cited by 400
Mechanisms of Membrane Transport of Folates into Cells and Across Epithelia
Zhao, R., Diop-Bove, N., Visentin, M., & Goldman, I. D. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145133 · Cited by 365
The folate receptor: What does it promise in tissue-targeted therapeutics?
Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350
Tumor detection using folate receptor-targeted imaging agents
Sega, E. I., & Low, P. S. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9155-6 · Cited by 291
Brugger, W., Triller, N., Blasinska-Morawiec, M., Curescu, S., Sakalauskas, R., Manikhas, G. M., Mazieres, J., Whittom, R., Ward, C., Mayne, K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.8162 · Cited by 279
Folate receptor overexpression is associated with poor outcome in breast cancer
Hartmann, L. C., Keeney, G. L., Lingle, W. L., Christianson, T. J. H., Varghese, B., Hillman, D., Oberg, A. L., & Low, P. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22811 · Cited by 245
Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
O'Shannessy, D. J., Yu, G., Smale, R., Fu, Y.-S., Singhal, S., Thiel, R. P., Somers, E. B., & Vachani, A. (2012) · Oncotarget · doi:10.18632/oncotarget.519 · Cited by 242
Systemic cancer therapy: achievements and challenges that lie ahead
Palumbo, M. O., Kavan, P., Miller, W. H., Panasci, L., Assouline, S., Johnson, N., Cohen, V., Patenaude, F., Pollak, M., Jagoe, R. T., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00057 · Cited by 241
Engineering Folate–Drug Conjugates to Target Cancer: From Chemistry to Clinic
Vlahov, I. R., & Leamon, C. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2005522 · Cited by 240
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
Gonzalez de Castro, D., Clarke, P. A., Al-Lazikani, B., & Workman, P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.237 · Cited by 239
Naumann, R. W., Coleman, R. L., Burger, R. A., Sausville, E. A., Kutarska, E., Ghamande, S. A., Gabrail, N. Y., DePasquale, S. E., Nowara, E., Gilbert, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7685 · Cited by 238
Tian, Q., Price, N. D., & Hood, L. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02498.x · Cited by 224
Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical
Leamon, C. P., Parker, M. A., Vlahov, I. R., Xu, L.-C., Reddy, J. A., Vetzel, M., & Douglas, N. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0200430 · Cited by 210
Design and Synthesis of [111In]DTPA−Folate for Use as a Tumor-Targeted Radiopharmaceutical
Wang, S., Luo, J., Lantrip, D. A., Waters, D. J., Mathias, C. J., Green, M. A., Fuchs, P. L., & Low, P. S. (1997) · Bioconjugate Chemistry · doi:10.1021/bc9701297 · Cited by 202
Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Toffoli, G., Russo, A. G., Gallo, A., Cernigoi, C., Miotti, S., Sorio, R., & Boiocchi, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2<121::aid-ijc4>3.0.co;2-v · Cited by 164
Armstrong, D. K., White, A. J., Weil, S. C., Phillips, M. D., & Coleman, R. L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.002 · Cited by 153
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
Polley, M.-Y. C., Freidlin, B., Korn, E. L., Conley, B. A., Abrams, J. S., & McShane, L. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt282 · Cited by 151
Overcoming implementation challenges of personalized cancer therapy
Meric‐Bernstam, F., & Mills, G. B. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.127 · Cited by 150
Vergote, I. B., Marth, C., & Coleman, R. L. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9539-8 · Cited by 148
Chen, Y., Chang, M., Huang, C., Chiang, Y., Lin, H.-W., Chen, C., Hsieh, C., & Cheng, W. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.11.010 · Cited by 145
99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging.
Guo, W., Hinkle, G. H., & Lee, R. J. (1999) · PubMed · Cited by 144
Momentum grows to make 'personalized' medicine more 'precise'
Katsnelson, A. (2013) · Nature Medicine · doi:10.1038/nm0313-249 · Cited by 143
Fisher, R. E., Siegel, B. A., Edell, S. L., Oyesiku, N. M., Morgenstern, D. E., Messmann, R. A., & Amato, R. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049478 · Cited by 143
Personalizing Oncology: Perspectives and Prospects
Mendelsohn, J. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3605 · Cited by 137
Siegel, B. A., Dehdashti, F., Mutch, D. G., Podoloff, D. A., Wendt, R. E., Sutton, G. P., Burt, R. W., Ellis, P. R., Mathias, C. J., Green, M. A., et al. (2003) · PubMed · Cited by 136
Vlahov, I. R., Santhapuram, H. K. R., Kleindl, P. J., Howard, S. J., Stanford, K., & Leamon, C. P. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.030 · Cited by 128
AOCS Study Group, Köbel, M., Madore, J., Ramus, S. J., Clarke, B. A., Pharoah, P. D. P., Deen, S., Bowtell, D. D. L., Odunsi, K. O., Menon, U., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.567 · Cited by 118
Karagiannis, S. N., Wang, Q., East, N., Burke, F., Riffard, S., Bracher, M. G., Thompson, R. G., Durham, S. R., Schwartz, L. B., Balkwill, F. R., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200323185 · Cited by 116
Morris, R. T., Joyrich, R. N., Naumann, R. W., Shah, N. P., Maurer, A. H., Strausś, H. W., Uszler, J. M., Symanowski, J. T., Ellis, P. R., & Harb, W. A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu024 · Cited by 115
Tumor control versus adverse events with targeted anticancer therapies
Keefe, D. M. K., & Bateman, E. H. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.192 · Cited by 113
Gould, H. J., Mackay, G. A., Karagiannis, S. N., O'Toole, C. M., Marsh, P. J., Daniel, B. E., Coney, L. R., Zurawski, V. R., Joseph, M., Capron, M., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3527::aid-immu3527>3.0.co;2-5 · Cited by 110
Iwakiri, S., Sonobe, M., Nagai, S., Hirata, T., Wada, H., & Miyahara, R. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9755-3 · Cited by 107
Shia, J., Klimstra, D. S., Nitzkorski, J. R., Low, P. S., Gonen, M., Landmann, R., Weiser, M. R., Franklin, W. A., Prendergast, F. G., Murphy, L., et al. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.013 · Cited by 106
Gibbs, D. D., Theti, D. S., Wood, N., Green, M., Raynaud, F. I., Valenti, M. R., Forster, M. D., Mitchell, F., Bavetsias, V., Henderson, E. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2034 · Cited by 101
Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors
LoRusso, P. M., Edelman, M. J., Bever, S. L., Forman, K., Pilat, M., Quinn, M. F., Li, J., Heath, E. I., Malburg, L., Klein, P. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.4946 · Cited by 98
The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
Crane, L. M. A., Arts, H. J. G., van Oosten, M., Low, P. S., van der Zee, A. G. J., van Dam, G. M., & Bart, J. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0052-6 · Cited by 88
Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
Basal, E., Eghbali-Fatourechi, G. Z., Kalli, K. R., Hartmann, L. C., Goodman, K. M., Goode, E. L., Kamen, B. A., Low, P. S., & Knutson, K. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006292 · Cited by 84
Bottero, F., Tomassetti, A., Canevari, S., S., M., Ménard, S., & COLNAGHI, M. I. (1993) · PubMed · Cited by 83
Self-citationMiotti, S., Bagnoli, M., Tomassetti, A., COLNAGHI, M. I., & Canevari, S. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.349 · Cited by 81
Self-citationComparative preclinical activity of the folate‐targeted Vinca alkaloid conjugates EC140 and EC145
Leamon, C. P., Reddy, J. A., Vlahov, I. R., Westrick, E. M., Parker, N. L., Nicoson, J. S., & Vetzel, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22853 · Cited by 79
Mathias, C. J., Wang, S. S., Low, P. S., Waters, D. J., & Green, M. A. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00076-6 · Cited by 76
Despierre, E., Lambrechts, S., Leunen, K., Berteloot, P., Neven, P., Amant, F., O'Shannessy, D. J., Somers, E. B., & Vergote, I. B. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.024 · Cited by 75
Maurer, A. H., Elsinga, P. H., Fanti, S., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.133074 · Cited by 70
Figini, M., Ferri, R., Mezzanzanica, D., Bagnoli, M., Luison, E., Miotti, S., & Canevari, S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301962 · Cited by 69
Self-citationHiss, D. C. (2012) · Journal of Oncology · doi:10.1155/2012/737981 · Cited by 63
Wen, Y., Graybill, W. A. S., Previs, R. A., Hu, W., Ivan, C., Mangala, L. S., Zand, B., Nick, A. M., Jennings, N. B., Dalton, H. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1578 · Cited by 62
Lin, J., Spidel, J. L., Maddage, C. J., Rybinski, K. A., Kennedy, R., Krauthauser, C., Park, Y. C., Albone, E. F., Jacob, S. M., Goserud, M. T., et al. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26106 · Cited by 53
O'Shannessy, D. J., Somers, E. B., Palmer, L. M., Thiel, R. P., Oberoi, P., Heath, R., & Marcucci, L. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-29 · Cited by 52
Rudman, S. M., Josephs, D. H., Cambrook, H., Karagiannis, P., Gilbert, A. E., Dodev, T. S., Hunt, J., Koers, A., Montes, A., Taams, L. S., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03770.x · Cited by 44
Self-citationEC145: a novel targeted agent for adenocarcinoma of the lung
Pribble, P., & Edelman, M. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.671294 · Cited by 40
A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells
Tian, Y., Wu, G., Xing, J., Tang, J., Zhang, Y., Huang, Z., Jia, Z., Zhao, R., Tian, Z., Wang, S., et al. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-30 · Cited by 40
Kamen, B. A., & Smith, A. K. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1890-2 · Cited by 39
An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients
Huang, H., Zheng, Y., Zhu, J., Zhang, J., Chen, H., & Chen, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089960 · Cited by 38
Clinical use of crizotinib for the treatment of non-small cell lung cancer
Roberts, P. J. (2013) · Biologics · doi:10.2147/btt.s29026 · Cited by 38
Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
Edelman, M. J., Harb, W. A., Pal, S. E., Boccia, R. V., Kraut, M., Bonomi, P., Conley, B. A., Rogers, J., Messmann, R. A., & Garon, E. B. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318267d051 · Cited by 36
Thomas, A., Maltzman, J. D., & Hassan, R. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2012.12.021 · Cited by 27
Al‐Jammaz, I., Al-Otaibi, B., Alrumayan, F., Al-Yanbawi, S., Amer, S. M. B., & Okarvi, S. M. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.03.013 · Cited by 13
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
Villaflor, V. M., & Salgia, R. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.109253 · Cited by 13
Hanna, N. H., Juhász, É., Cainap, C. I., Gladkov, O. A., Ramlau, R., Juan, Ó., Lal, R., Symanowski, J. T., Perez, W., Nguyen, B., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu438.48 · Cited by 12
Clinical utility of targeted treatments in the management of epithelial ovarian cancer
Han, E. S., & Twu, C. (2012) · Biologics · doi:10.2147/btt.s29356 · Cited by 6
Cited by
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Attia, M. F., Anton, N., Wallyn, J., Omran, Z., & Vandamme, T. F. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13098 · Cited by 1,085
Advances in ovarian cancer therapy
Cortez, A. J., Tudrej, P., Kujawa, K. A., & Lisowska, K. M. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3501-8 · Cited by 624
Exploiting the folate receptor α in oncology
Scaranti, M., Cojocaru, E., Banerjee, S., & Banerji, U. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0339-5 · Cited by 593
Advances in targeting the folate receptor in the treatment/imaging of cancers
Fernández, M., Javaid, F., & Chudasama, V. (2018) · Chemical Science · doi:10.1039/c7sc04004k · Cited by 539
Metadata
- Authors
- Ledermann, J. A., Canevari, S., & Thigpen, T.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 26
- Issue
- 10
- Pages
- 2034-2043
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W1911328979
- Cited by
- 347
- References
- 77
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.